|
|
|
|
Lenacapavir Plus bNAbs for People with HIV and Susceptibility to Either Teropavimab or Zinlirvimab
|
|
|
CROI 2024 March 3-6 Denver
Joseph J Eron,1 Paul P Cook,2 Megha L Mehrotra,3 Hailin Huang,3 Marina Caskey,4 Gordon E Crofoot,5 Edwin DeJesus,6 Linda Gorgos,7 Laurie A VanderVeen,3 Olayemi O Osiyemi,8 Cynthia Brinson,9 Sean E Collins3
|
|
|
|
|
|
|